And furthermore, the role of CML in the development of atherosclerotic calcification in diabetic patients and the underlying mechanism also remain unclear

And furthermore, the role of CML in the development of atherosclerotic calcification in diabetic patients and the underlying mechanism also remain unclear. investigated in A7r5 aortic smooth muscle cells under high-lipid, apoptosis-coexisting conditions. ELISA (for serum CML concentration of patients), 5-Aminosalicylic Acid ultrasound (for plaque size, calcification, blood flow filling, vascular stenosis etc . ), H&E staining (for plaque morphology), vonKossa staining (for qualitative analysis of calcification), calcium content assay (for quantitative analysis of calcification), and 5-Aminosalicylic Acid Western blot analyses of CML, receptor for advanced glycation end products (RAGE), NADPH oxidase 4, phosphorylated 5-Aminosalicylic Acid p38, core-binding factor 1 (cbf1), alkaline phosphatase (ALP) and -actin were then performed. == Results == Morphological analysis revealed extensive calcification lesions in the intima and media of the anterior tibial artery. The extent and area of calcium deposition in the intima significantly increased with disease progression. Interestingly, spotty calcification was predominant in the atherosclerotic plaques of diabetic patients with amputation, and macrocalcification was almost invisible. Pearson correlation analysis revealed that serum CML level exhibited a significant positive correlation with calcium content in the arterial wall (R2= 0. 6141, P < 0. 0001). Semi-quantitative Western blot analysis suggested that the intensity of CML/RAGE signal increased with progression of atherosclerotic calcification in diabetic patients. In subsequent in vitro study, the related pathway was blocked by anti-RAGE antibody, NADPH oxidase inhibitor DPI, p38MAPK inhibitor SB203580, and anti-cbfa1 antibody in a step-wise manner to observe changes in 5-Aminosalicylic Acid calcium deposition and molecular signals. Results suggested that CML may play a key role in atherosclerotic calcification mainly through the CML/RAGE- reactive oxygen species (ROS)-p38MAPK-cbf1-ALP 5-Aminosalicylic Acid pathway. == Conclusion == Spotty calcification was predominant in the atherosclerotic plaques of amputated diabetic patients. CML/RAGE signal may induce the calcification cascade in diabetes via ROS-p38MAPK. Keywords: Advanced glycation end-products, p38MAPK, Vascular calcification, Atherosclerosis, Diabetic foot == Background == The International Diabetes Federation reported that the number of diabetic patients worldwide was 387 million in 2014 and is predicted to reach 592 million by 2035 [1]. China has the highest number of people with diabetes, which accounts for about one-third of the total number of diabetic patients worldwide [1]. Patients with diabetes commonly manifest vascular calcification, including intima and medial calcification, which are mainly distributed in the coronary artery and lower extremity vessels, respectively [2, 3]. A multi-center epidemiological study demonstrated that the risk of acute cardiovascular events in patients with calcification score > 300 is significantly higher than those in patients with calcification score of 1100 [4, 5]. Studies showed that the degree of vascular calcification could be the optimal predictor of cardiovascular mortality, stroke incidence, and risk of lower limb amputation Rabbit polyclonal to FOXO1-3-4-pan.FOXO4 transcription factor AFX1 containing 1 fork-head domain.May play a role in the insulin signaling pathway.Involved in acute leukemias by a chromosomal translocation t(X;11)(q13;q23) that involves MLLT7 and MLL/HRX. in patients with diabetes mellitus [48]. Thus, further insights into the mechanism of calcification in diabetic atherosclerosis exhibit theoretical and social significance. Vascular calcification is an active process in which vascular smooth muscle cells (VSMCs) adopt an osteoblastic phenotype and deposit hydroxyapatite crystals [9]. Our previous studies showed that N-carboxymethyl-lysine (CML), a key active ingredient of heterogeneous AGEs, could promote the transdifferentiation of VSMC phenotype and the formation of aortic calcification in diabetic mice [10]. Its well known that advanced glycation end-products (AGEs) are metabolic products of glucose toxicity and play a significant role in the development of diabetes and its multiple complications. Studies showed that AGEs could accumulate in many tissues and organs, such as skin, kidney, and aorta wall [11, 12]. High baseline AGE levels are significantly associated with plaque progression after adjusting for diabetes mellitus in multivariate logistic regression models [13]. In.